NIDDK Central Repository

NIDDK Central Repository
Name	NIDDK Central Repository
Established	2003
Type	Biomedical data and biospecimen archive
Jurisdiction	United States
Parent agency	National Institutes of Health

NIDDK Central Repository is a biomedical data and biospecimen archive that supports secondary research by preserving and distributing clinical, genetic, and laboratory data. It serves as a centralized resource linking studies from the National Institute of Diabetes and Digestive and Kidney Diseases, coordinating submissions from consortia such as The Diabetes Control and Complications Trial and The Diabetes Prevention Program, and interacting with federal programs including the National Institutes of Health and the United States Department of Health and Human Services. The Repository facilitates reuse of materials originating from cooperative studies involving organizations like the Eunice Kennedy Shriver National Institute of Child Health and Human Development and initiatives connected to the Human Genome Project.

Overview

The Repository functions as a curated archive connecting datasets, biospecimens, and documentation from clinical trials and cohort studies sponsored by entities such as the National Heart, Lung, and Blood Institute, Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality. Its holdings support cross-study analyses that integrate genotype information from collaborations with projects related to the International HapMap Project and phenotype data that complement resources like the Framingham Heart Study and the Jackson Heart Study. Users typically include investigators from academic institutions such as Harvard University, Johns Hopkins University, and the University of California, San Francisco, as well as researchers affiliated with consortia like the Consortium of Metabolomics Studies and the Alzheimer's Disease Neuroimaging Initiative.

History and Development

The Repository was established in the context of data-sharing mandates and infrastructure efforts led by agencies such as the National Institutes of Health and policy discussions influenced by reports from the Institute of Medicine. Early development drew on models from archives like the dbGaP platform and federated systems exemplified by the Database of Genotypes and Phenotypes and the Genotype-Tissue Expression project. Founding partnerships involved cooperative agreements with academic centers including University of Washington, University of Michigan, and Vanderbilt University, and collaborations with large-scale trials such as The Diabetes Control and Complications Trial and epidemiologic efforts like the Multi-Ethnic Study of Atherosclerosis. Over time governance evolved alongside federal initiatives such as the Data Access Committee frameworks and compliance regimes influenced by statutes like the Health Insurance Portability and Accountability Act.

Collections and Data Holdings

Holdings comprise clinical datasets, coded phenotype variables, genomic assay results, and biospecimen inventories linked to studies including The Diabetes Prevention Program, Action to Control Cardiovascular Risk in Diabetes, and the Chronic Kidney Disease Prognosis Consortium. The Repository maintains specimen catalogs with aliquot-level metadata derived from laboratories at institutions such as Mayo Clinic, Cleveland Clinic, and Massachusetts General Hospital, and genetic data produced in collaboration with centers like the Broad Institute and Wellcome Trust Sanger Institute. Documentation includes protocol manuals, case report forms, and data dictionaries that reference standards promoted by organizations such as the Clinical Data Interchange Standards Consortium and the National Library of Medicine.

Access and Use Policies

Access procedures align with policies from the National Institutes of Health and require submission of proposals reviewed by access committees modeled on mechanisms used by the dbGaP Data Access Committees and the Wellcome Trust. Users must obtain institutional approvals from entities like university institutional review boards at Stanford University, Columbia University, or Yale University and comply with consent restrictions similar to those interpreted under the Common Rule. Data-use agreements outline obligations concerning privacy protections shaped by precedents from cases reviewed by courts such as the United States Court of Appeals for the Second Circuit and guidance from agencies including the Office for Human Research Protections.

Governance and Funding

Administrative oversight involves program officers and contracts managed by divisions within the National Institute of Diabetes and Digestive and Kidney Diseases and coordination with the National Institutes of Health Office of Data Science Strategy, with technical partners from institutions such as RTI International and Westat. Funding streams derive primarily from congressional appropriations through the United States Department of Health and Human Services and are supplemented by cooperative agreements with research networks like the Clinical and Translational Science Awards program and contributions tied to awards from the National Heart, Lung, and Blood Institute. Policy direction has been informed by advisory groups including panels convened by the Institute of Medicine and stakeholder feedback from consortia such as the Global Alliance for Genomics and Health.

Impact and Contributions

The Repository has enabled secondary analyses that produced findings cited in publications from investigators at University of Cambridge, Imperial College London, and the Karolinska Institutet, and has supported translational research informing guidelines from organizations like the American Diabetes Association and the Kidney Disease: Improving Global Outcomes foundation. By preserving data from landmark studies including The Diabetes Control and Complications Trial and The Diabetes Prevention Program, it has facilitated meta-analyses and pooled studies that intersect with resources such as the National Health and Nutrition Examination Survey and the UK Biobank. Its role in data stewardship has influenced policy discussions in forums hosted by the National Academies of Sciences, Engineering, and Medicine and contributed to methodological advances implemented at centers like the Broad Institute and Johns Hopkins University.

Category:Biorepositories